Vascular endothelial growth factor protects post-ganglionic sympathetic neurones from the detrimental effects of hydrogen peroxide by increasing catalase

Acta Physiologica

Volumn 203, Issue 1, 2011, Pages 271-278

  Damon, D H ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Catalase; Hyperglycaemia; Neuronal protection; Reactive oxygen species; Sympathetic innervation; Vascular endothelial growth factor

Indexed keywords

CATALASE; GLUCOSE; HYDROGEN PEROXIDE; NEUROMODULIN; NORADRENALIN; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE UPTAKE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

ANIMALS; BLOTTING, WESTERN; CATALASE; CELL SURVIVAL; CELLS, CULTURED; HYDROGEN PEROXIDE; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SYMPATHETIC FIBERS, POSTGANGLIONIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051663253     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02258.x     Document Type: Article

References (54)

1. Ardanaz, N. & Pagano, P.J. 2006. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med 231, 237-251.
2. Aronson, D. 2008. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45, 1-16.
3. Avshalumov, M.V., Chen, B.T., Koos, T., Tepper, J.M. & Rice, M.E. 2005. Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 25, 4222-4231.
4. Barber, S.C. & Shaw, P.J. 2010. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48, 629-641.
5. Calcutt, N.A., Cooper, M.E., Kern, T.S. & Schmidt, A.M. 2009. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 8, 417-429.
6. Caló, L.A., Davis, P.A., Cantaro, S., Bonfante, L., Castrignano, R., Carraro, G. & D'Angelo, A. 1998. Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes. Acta Diabetol 35, 96-100.
7. Chattopadhyay, M., Krisky, D., Wolfe, D., Glorioso, J.C., Mata, M. & Fink, D.J. 2005. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 12, 1377-1384.
8. Csányi, G., Taylor, W.R. & Pagano, P.J. 2009. NOX and inflammation in the vascular adventitia. Free Radic Biol Med 47, 1254-1266.
9. Damon, D.H. 2001. NGF-independent survival of postganglionic sympathetic neurons in neuronal/vascular cocultures. Am J Physiol Heart Circ Physiol 280, H1722-H1728.
10. Damon, D.H. 2006. Vascular endothelial-derived semaphorin 3A inhibits sympathetic axon growth. Am J Physiol Heart and Circ Physiol 290, H1220-H1225.
11. Durand, E., Zen, Al., Haj, A., Addad, F., Brasselet, C., Caligiuri, G., Vinchon, F., Lemarchand, P., Desnos, M., Bruneval, P. & Lafont, A. 2005. Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. J Vasc Res 42, 255-265.
12. Faraci, F.M. 2006. Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler Thromb Vasc Biol 26, 1931-1933.
13. Fatokun, A.A., Stone, T.W. & Smith, R.A. 2007. Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures. Neurosci Lett 416, 34-38.
14. Fatokun, A.A., Stone, T.W. & Smith, R.A. 2008. Oxidative stress in neurodegeneration and available means of protection. Front Biosci 13, 3288-3311.
15. Feldman, E.L. 2003. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 111, 1-3.
16. Fitzgerald, S.M. & Brands, M.W. 2002. Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system. Am J Physiol Regul Integr Comp Physiol 282, R1070-R1076.
17. Gáspár, T., Domoki, F., Lenti, L., Institoris, A., Snipes, J.A., Bari, F. & Busija, D.W. 2009. Neuroprotective effect of adenoviral catalase gene transfer in cortical neuronal cultures. Brain Res 1270, 1-9.
18. Glebova, N.O. & Ginty, D.D. 2005. Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 28, 191-222.
19. Guyenet, P.G. 2006. The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
20. Haurani, M.J. & Pagano, P.J. 2007. Adventitial fibroblast reactive oxygen species as autocrine and paracrine mediators of remodeling: bellwether for vascular disease? Cardiovasc Res 75, 679-689.
21. Jackson, G.R., Apffel, L., Werrbach-Perez, K. & Perez- Polo, J.R. 1990. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J Neurosci Res 25, 360-368.
22. Johnson, C.D., Coney, A.M. & Marshall, J.M. 2001. Roles of norepinephrine and ATP in sympathetically evoked vasoconstriction in rat tail and hindlimb in vivo. Am J Physiol Heart Circ Physiol 281, H2432-H2440.
23. Karoon, P., Rubino, A. & Burnstock, G. 1995. Enhanced sympathetic neurotransmission in the tail artery of 1, 3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats. Br J Pharmacol 116, 1918-1922.
24. Levi-Montalcini, R. & Booker, B. 1960. Destruction of the sympathetic ganglia in mammals by an antiserum to the nerve growth-promoting factor. Proc Natl Acad Sci USA 46, 384-391.
25. Li, B., Xu, W., Luo, C., Gozal, D. & Liu, R. 2003. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res 111, 155-164.
26. Li, Y., Zhang, F., Nagai, N., Tang, Z., Zhang, S., Scotney, P., Lennartsson, J., Zhu, C., Qu, Y., Fang, C. et al. 2008. VEGF-B inhibits apoptosis via VEGFR-1 mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 118, 913-923.
27. Lichtor, T., Davis, H.R., Johns, L., Vesselinovitch, D., Wissler, R.W. & Mullan, S. 1987. The sympathetic nervous system and atherosclerosis. J Neurosurg 67, 906-914.
28. Lin, Y.Y., Tseng, T.J., Hsieh, Y.L., Luo, K.R., Lin, W.M., Chiang, H. & Hsieh, S.T. 2008. Depletion of peptidergic innervation in the gastric mucosa of streptozotocin-induced diabetic rats. Exp Neurol 213, 388-396.
29. Long, J.B., Jay, S.M., Segal, S.S. & Madri, J.A. 2009. VEGF-A and semaphorin3A: modulators of vascular sympathetic innervation. Dev Biol 334, 119-132.
30. Lourenssen, S., Miller, K.G. & Blennerhassett, M.G. 2009. Discrete response of myenteric neurons to structural and functional damage by neurotoxins in vitro. Am J Physiol Gastrointest Liver Physiol 297, G228-G239.
31. Lunn, J.S., Sakowski, S.A., Kim, B., Roseberg, A.A. & Feldman, E.L. 2009. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev Neurobiol 69, 871-884.
32. Luther, J.A. & Birren, S.J. 2009. Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic properties. Auton Neurosci 151, 46-60.
33. Madamanchi, N.R., Vendrov, A. & Runge, A.S. 2005. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25, 29-38.
34. Marko, S.B. & Damon, D.H. 2008. VEGF promotes vascular sympathetic innervation. Am J Physiol Heart Circ Physiol 294, H2646-H2652.
35. Murakami, T., Arai, M., Aunada, Y. & Nakamura, A. 2006. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J Gene Med 8, 773-781.
36. Natarajan, R., Bai, W., Lanting, L., Gonzales, N. & Nadler, J. 1997. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol (Heart Circ Physiol 42) 273, H2224-H2231.
37. Nishijima, K., Ng, Y.-S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S.J., Robinson, G.S., Adamis, A.P. & Shima, D.T. 2007. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171, 53-67.
38. Nizuma, K., Endo, H. & Chan, P.H. 2009. Oxidative stress and mitocondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 109(Suppl. 1), 133-138.
39. Pieró, C., Lafuente, N., Matesanz, N., Cercas, E., Llergo, J.L., Vallejo, S., Rodriguez-Mañas, L. & Sánchez-Ferrer, C.F. 2001. High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 133, 967-974.
40. Poesen, K., Lambrechts, D., Van Damme, P., Dhondt, J., Bender, F., Frank, N., Bogaert, E., Claes, B., Heylen, L., Verheyen, A. et al. 2008. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 28, 10451-10459.
41. Sakowski, S.A., Heavener, S.B., Lunn, J.S., Fung, K., Oh, S.S., Sprat, S.K., Hogikyan, N.D. & Feldman, E.L. 2009. Neuroprotection using gene therapy to induce vascular endothelial growth factor A-expression. Gene Ther 16, 1292-1299.
42. Sampath, D. & Perez-Polo, R. 1997. Regulation of antioxidant enzyme expression by NGF. Neurochem Res 22, 351-362.
43. Sampath, D., Jackson, G.R., Werrbach-Perez, K. & Perez-Polo, R. 1994. Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J Neurochem 62, 2476-2479.
44. Schrier, R.W. & Abraham, W.T. 1999. Hormones and hemodynamics in heart failure. N Engl J Med 31, 577-585.
45. Shi, Y. & Vanhoutte, P.M. 2008. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154, 639-651.
46. Son, S.M., Whalin, M.K., Harrison, D.G., Taylor, W.R. & Griendling, K.K. 2004. Oxidative stress and diabetic vascular complications. Curr Diab Rep 4, 247-252.
47. Sousa, T., Pinho, D., Morato, M., Marques-Lopes, J., Fernandes, E., Afonso, J., Oliveira, S., Carvalho, F. & Albino-Teixeira, A. 2008. Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 588, 267-276.
48. Stone, J.R. & Yang, S. 2006. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8, 243-270.
49. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno- Murciano, M.P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W.Y., De Mol, M. et al. 2005. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8, 85-92.
50. Storkebaum, E., de Almodovar, C.R., Meens, M., Zacchigna, S., Mazzone, M., Vanhoutte, G., Vinckier, S., Miskiewicz, K., Poesen, K., Lambrechts, D. et al. 2010. Impaired autonomic regulation of resistance arteries in mice with low vascular endothelial growth factor or upon vascular endothelial growth factor trap delivery. Circulation 122, 273-281.
51. Sun, F.-Y. & Guo, X. 2005. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79, 180-184.
52. Yang, H., Roberts, L.J., Shi, M.J., Zhou, L.C., Ballard, B.R., Richardson, A. & Guo, Z.M. 2004. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 95, 1075-1081.
53. Zhang, L., Zalewski, A., Liu, Y., Mazurek, T., Cowan, S., Martin, J.L., Hofmann, S.M., Vlassara, H. & Shi, Y. 2003. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108, 472-478.
54. 2. Hypertension 46, 732-737.